275 related articles for article (PubMed ID: 11456714)
1. Hydroxylation of camphor by reduced oxy-cytochrome P450cam: mechanistic implications of EPR and ENDOR studies of catalytic intermediates in native and mutant enzymes.
Davydov R; Makris TM; Kofman V; Werst DE; Sligar SG; Hoffman BM
J Am Chem Soc; 2001 Feb; 123(7):1403-15. PubMed ID: 11456714
[TBL] [Abstract][Full Text] [Related]
2. Cryoreduction EPR and 13C, 19F ENDOR study of substrate-bound substates and solvent kinetic isotope effects in the catalytic cycle of cytochrome P450cam and its T252A mutant.
Kim SH; Yang TC; Perera R; Jin S; Bryson TA; Sono M; Davydov R; Dawson JH; Hoffman BM
Dalton Trans; 2005 Nov; (21):3464-9. PubMed ID: 16234926
[TBL] [Abstract][Full Text] [Related]
3. Substrate modulation of the properties and reactivity of the oxy-ferrous and hydroperoxo-ferric intermediates of cytochrome P450cam as shown by cryoreduction-EPR/ENDOR spectroscopy.
Davydov R; Perera R; Jin S; Yang TC; Bryson TA; Sono M; Dawson JH; Hoffman BM
J Am Chem Soc; 2005 Feb; 127(5):1403-13. PubMed ID: 15686372
[TBL] [Abstract][Full Text] [Related]
4. The use of deuterated camphor as a substrate in (1)H ENDOR studies of hydroxylation by cryoreduced oxy P450cam provides new evidence of the involvement of compound I.
Davydov R; Dawson JH; Perera R; Hoffman BM
Biochemistry; 2013 Jan; 52(4):667-71. PubMed ID: 23215047
[TBL] [Abstract][Full Text] [Related]
5. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
Narasimhulu S
Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
[TBL] [Abstract][Full Text] [Related]
6. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.
Davydov R; Strushkevich N; Smil D; Yantsevich A; Gilep A; Usanov S; Hoffman BM
Biochemistry; 2015 Dec; 54(48):7089-97. PubMed ID: 26603348
[TBL] [Abstract][Full Text] [Related]
7. Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
Davydov R; Gilep AA; Strushkevich NV; Usanov SA; Hoffman BM
J Am Chem Soc; 2012 Oct; 134(41):17149-56. PubMed ID: 23039857
[TBL] [Abstract][Full Text] [Related]
8. EPR and ENDOR characterization of intermediates in the cryoreduced oxy-nitric oxide synthase heme domain with bound L-arginine or N(G)-hydroxyarginine.
Davydov R; Ledbetter-Rogers A; Martásek P; Larukhin M; Sono M; Dawson JH; Masters BS; Hoffman BM
Biochemistry; 2002 Aug; 41(33):10375-81. PubMed ID: 12173923
[TBL] [Abstract][Full Text] [Related]
9. Reduced oxy intermediate observed in D251N cytochrome P450cam.
Benson DE; Suslick KS; Sligar SG
Biochemistry; 1997 Apr; 36(17):5104-7. PubMed ID: 9136869
[TBL] [Abstract][Full Text] [Related]
10. EPR and ENDOR characterization of the reactive intermediates in the generation of NO by cryoreduced oxy-nitric oxide synthase from Geobacillus stearothermophilus.
Davydov R; Sudhamsu J; Lees NS; Crane BR; Hoffman BM
J Am Chem Soc; 2009 Oct; 131(40):14493-507. PubMed ID: 19754116
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic studies of peroxyacetic acid reaction intermediates of cytochrome P450cam and chloroperoxidase.
Schünemann V; Jung C; Terner J; Trautwein AX; Weiss R
J Inorg Biochem; 2002 Sep; 91(4):586-96. PubMed ID: 12237224
[TBL] [Abstract][Full Text] [Related]
12. Resonance Raman and EPR investigations of the D251N oxycytochrome P450cam/putidaredoxin complex.
Sjodin T; Christian JF; Macdonald ID; Davydov R; Unno M; Sligar SG; Hoffman BM; Champion PM
Biochemistry; 2001 Jun; 40(23):6852-9. PubMed ID: 11389599
[TBL] [Abstract][Full Text] [Related]
13. A theoretical study on the mechanism of camphor hydroxylation by compound I of cytochrome p450.
Kamachi T; Yoshizawa K
J Am Chem Soc; 2003 Apr; 125(15):4652-61. PubMed ID: 12683838
[TBL] [Abstract][Full Text] [Related]
14. Resonance Raman characterization of the peroxo and hydroperoxo intermediates in cytochrome P450.
Denisov IG; Mak PJ; Makris TM; Sligar SG; Kincaid JR
J Phys Chem A; 2008 Dec; 112(50):13172-9. PubMed ID: 18630867
[TBL] [Abstract][Full Text] [Related]
15. Unexpected Differences between Two Closely Related Bacterial P450 Camphor Monooxygenases.
Murarka VC; Batabyal D; Amaya JA; Sevrioukova IF; Poulos TL
Biochemistry; 2020 Jul; 59(29):2743-2750. PubMed ID: 32551522
[TBL] [Abstract][Full Text] [Related]
16. The catalytic pathway of cytochrome p450cam at atomic resolution.
Schlichting I; Berendzen J; Chu K; Stock AM; Maves SA; Benson DE; Sweet RM; Ringe D; Petsko GA; Sligar SG
Science; 2000 Mar; 287(5458):1615-22. PubMed ID: 10698731
[TBL] [Abstract][Full Text] [Related]
17. On the identity and reactivity patterns of the "second oxidant" of the T252A mutant of cytochrome P450cam in the oxidation of 5-methylenenylcamphor.
Hirao H; Kumar D; Shaik S
J Inorg Biochem; 2006 Dec; 100(12):2054-68. PubMed ID: 17084458
[TBL] [Abstract][Full Text] [Related]
18. Stereochemistry and deuterium isotope effects in camphor hydroxylation by the cytochrome P450cam monoxygenase system.
Gelb MH; Heimbrook DC; Mälkönen P; Sligar SG
Biochemistry; 1982 Jan; 21(2):370-7. PubMed ID: 7074020
[TBL] [Abstract][Full Text] [Related]
19. Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism.
Nagano S; Poulos TL
J Biol Chem; 2005 Sep; 280(36):31659-63. PubMed ID: 15994329
[TBL] [Abstract][Full Text] [Related]
20. Catalytic mechanism of heme oxygenase through EPR and ENDOR of cryoreduced oxy-heme oxygenase and its Asp 140 mutants.
Davydov R; Kofman V; Fujii H; Yoshida T; Ikeda-Saito M; Hoffman BM
J Am Chem Soc; 2002 Feb; 124(8):1798-808. PubMed ID: 11853459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
